Analyspodden - bolag & aktier med DNB Carnegie

Analyspodden is a Swedish equity-analysis program built for listeners who want the business case before the share case. It treats a company story as something that has to survive detailed questioning. Episodes often begin with a recent analyst report, a newly covered company, or a focused sector theme. The format is interview-led, but the pace is controlled. Company guests and analysts get room to describe what the company actually sells, where demand comes from, and which markets matter. Then the discussion turns toward the numbers. Revenue mix, EBIT margins, peer multiples, acquisition targets, clinical data, regulatory approvals, and geographic expansion all appear as practical parts of the same investment argument. The show is at its best when technical fields are made legible without being flattened. A conversation about OstDesign moves from nanosynthetic bone grafts to U.S. hospital access and adjacent orthopedic segments. A life-science episode explains immuno-oncology, clinical data, market approvals, and the very high risk attached to biotech cases. A Job Solution discussion follows staffing, consulting, Nordic acquisitions, valuation discounts, and a billion-krona revenue ambition. Retail and consumer episodes widen the lens again, with Björn Borg, online sales, sports apparel, books, subscription services, and local-language markets. The tone stays measured. It can be enthusiastic about a strong case, but it does not sell excitement as analysis. Questions keep returning to scale, profitability, defensibility, and what the market may already be pricing in. The result feels close to sitting beside an equity research conversation as a thesis is being built in public. It is not casual business banter. It is not a pure news recap either. It is a practical bridge between company presentations and research notes, with enough structure for non-specialists and enough detail for active market followers.